Entyvio

UNIISPLATC L04AG05

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerTakeda Pharmaceuticals America, Inc.

CountryUS (United States)

ATC codeL04AG05

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 1

ndc11
6476430020
1 VIAL, SINGLE-DOSE in 1 CARTON (64764-300-20) / 5 mL in 1 VIAL, SINGLE-DOSE

Annotations

UNII (FDA Substance ID)

9RV78Q2002

VEDOLIZUMAB

RxCUI 1538097

DailyMed SPL labels

1 version tracked

Raw payload (JSON)

{
  "unii": {
    "unii": "9RV78Q2002",
    "rxcui": "1538097",
    "inchikey": null,
    "display_name": "VEDOLIZUMAB",
    "substance_type": "protein",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "spl_meta": {
    "6e94621c-1a95-4af9-98d1-52b9e6f1949c": {
      "match": "brand_token",
      "title": "ENTYVIO (VEDOLIZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ENTYVIO PEN (VEDOLIZUMAB) INJECTION, SOLUTION ENTYVIO (VEDOLIZUMAB) INJECTION, SOLUTION [TAKEDA PHARMACEUTICALS AMERICA, INC.]",
      "spl_version": "26",
      "published_date": "2026-05-13"
    }
  },
  "productid": "64764-300_266293d6-dd28-4e38-81c2-4f518d95ef5d",
  "productndc": "64764-300",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "VEDOLIZUMAB",
  "proprietary_name": "Entyvio",
  "active_ingred_unit": "mg/5mL",
  "application_number": "BLA125476",
  "marketing_category": "BLA",
  "nonproprietary_name": "vedolizumab",
  "start_marketing_date": "20140520",
  "active_numerator_strength": "300"
}

Related drugs

Other records sharing ATC code L04AG05.

Access this data programmatically

Query Entyvio and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs